MIDEAS

MIDEAS (ELMSAN1) is an essential scaffold protein of the MiDAC histone deacetylase complex that organizes chromatin-directed deacetylation programs governing mitosis, embryogenesis, cardiac development, and cancer cell identity (PMID:32591534). Together with DNTTIP1, whose amino-terminal dimerization domain nucleates assembly and whose carboxy-terminal SKI/SNO/DAC-related domain provides dimeric DNA- and nucleosome-binding, MIDEAS builds a multivalent complex that positions four peripheral HDAC1/2 molecules with outward-facing active sites for processive deacetylation of multiple nucleosomes (PMID:25653165, PMID:32591534). HDAC1 recruitment into the complex depends on a specific contact residue (HDAC1 Tyr48) that distinguishes MIDEAS-type ELM2/SANT recruitment from other deacetylase assemblies (PMID:40966515). A conserved auto-inhibitory loop in MIDEAS normally covers the HDAC active site, and a de novo p.Tyr654Ser variant displacing this loop hyperactivates MiDAC to cause a neurodevelopmental syndrome (PMID:41290615). Through this complex MIDEAS controls gene expression at the chromatin level — acting downstream of AHR to deacetylate MYC regulatory elements and repress MYC (PMID:40768599) and regulating H3K27 acetylation during cardiomyocyte differentiation and maturation (PMID:38904247). Independently of its chromatin role, MIDEAS directly binds and constitutively inhibits the nuclear pyruvate dehydrogenase complex, restraining nuclear acetyl-CoA production; disrupting this interaction reprograms cancer cells toward a postmitotic state, synergizing with HDAC1/2 inhibition (PMID:40505660). Loss of MIDEAS causes embryonic lethality with heart malformation and haematopoietic failure in mice and progressive cardiac dysfunction with mitochondrial and metabolic defects upon cardiomyocyte-specific deletion (PMID:32591534, PMID:40588350).

1. 2015 High

   Established that MIDEAS is a constituent of an HDAC1/2 deacetylase complex and defined how DNTTIP1 bridges MIDEAS to HDAC1 while tethering the complex to nucleosomes, answering how the complex assembles and engages chromatin.

   Evidence Crystal structures of DNTTIP1 domains with co-immunoprecipitation and nucleosome-binding assays

   PMID:25653165

   Open questions at the time

   • Did not resolve the full complex architecture or HDAC stoichiometry
   • MIDEAS-specific structural contributions not defined
   • No in vivo functional consequence established
2. 2020 High

   Resolved the unique multivalent MiDAC architecture with four peripheral HDAC1 molecules and demonstrated that MIDEAS is a non-redundant scaffold essential for embryogenesis, hematopoiesis, and mitotic chromosome alignment.

   Evidence CryoEM structure plus MIDEAS and DNTTIP1 knockout mice and cancer cell-line knockdown with mitotic readouts

   PMID:32591534

   Open questions at the time

   • Mechanistic basis of mitotic chromosome alignment defect not defined
   • Direct nucleosome substrate specificity in vivo not mapped
   • Tissue-specific gene programs controlled by MiDAC not enumerated
3. 2024 Medium

   Demonstrated that MIDEAS is required for cardiomyocyte differentiation and maturation and linked its function to H3K27 acetylation control, connecting the complex to a defined developmental gene program.

   Evidence ELMSAN1 knockdown and CRISPR knockout in hiPSCs with cardiac differentiation, sarcomere imaging, calcium imaging, electrophysiology, and transcriptomics

   PMID:38904247

   Open questions at the time

   • No direct biochemical reconstitution of the MIDEAS-histone axis
   • Specific H3K27ac target loci not defined
   • Single model system
4. 2025 High

   Pinpointed an auto-inhibitory loop residue (Tyr654) whose mutation hyperactivates MiDAC, establishing gain of deacetylase activity as the pathogenic mechanism of a neurodevelopmental syndrome.

   Evidence CryoEM structure with variant mapping, patient fibroblast transcriptomics, and comparison to a MiDAC-degraded cell line

   PMID:41290615

   Open questions at the time

   • Direct enzymatic measurement of activity gain not shown
   • Affected neurodevelopmental gene targets not defined
   • Single patient/variant
5. 2025 High

   Identified a chromatin-independent function: MIDEAS directly binds and constitutively inhibits the nuclear pyruvate dehydrogenase complex to limit nuclear acetyl-CoA, defining a metabolic node exploitable in cancer.

   Evidence Phenotypic chemical screen, genome-wide CRISPR screen, proteomics, and direct interaction studies with in vivo tumor validation

   PMID:40505660

   Open questions at the time

   • Structural basis of the ELMSAN1-nPDC interaction not resolved
   • How chromatin-bound versus nPDC-bound pools are partitioned unknown
   • Relationship between acetyl-CoA pool and MiDAC deacetylase output not directly tested
6. 2025 Medium

   Placed ELMSAN1 downstream of AHR transcriptional control as an effector that deacetylates MYC regulatory chromatin, linking a signaling input to MYC repression and BET inhibitor sensitivity in AML.

   Evidence Functional CRISPR screen, ChIP, ELMSAN1 depletion with MYC and BET inhibitor readouts, and patient-derived xenografts

   PMID:40768599

   Open questions at the time

   • Direct demonstration of MiDAC-mediated histone deacetylation at MYC loci limited
   • Generalizability beyond AML not established
   • AHR-to-ELMSAN1 promoter mechanism not fully mapped
7. 2025 High

   Defined HDAC1 Tyr48 as the contact residue distinguishing MIDEAS-type ELM2/SANT recruitment from SIN3 and MTA1 recruitment, explaining specificity of complex assembly.

   Evidence HDAC1-Flag Co-IP/MS, HDAC1 Y48E/E63R mutant rescue in HDAC1/2 double-KO cells, and comparative structural analysis

   PMID:40966515

   Open questions at the time

   • Functional consequence of selectively disrupting MIDEAS recruitment in vivo not tested
   • Whether other complex members compete for the same surface unresolved
8. 2025 Medium

   Showed that cardiomyocyte-specific Elmsan1 loss causes progressive cardiac dysfunction with mitochondrial and TCA-cycle gene suppression, tying MIDEAS to adult cardiac metabolic homeostasis.

   Evidence Cardiomyocyte-specific conditional KO mice with echocardiography, histology, RNA-seq, electron microscopy, and calcium imaging

   PMID:40588350

   Open questions at the time

   • Direct chromatin targets driving TCA/mitochondrial gene suppression not defined
   • Link to the nPDC/acetyl-CoA function not tested in heart
   • Single model and sex-dependent timing

• How MIDEAS partitions between its chromatin-deacetylation scaffold role and its nuclear PDC-inhibitory role, and how these jointly control nuclear acetyl-CoA and tissue-specific gene programs, remains unresolved.
• No unified model linking acetyl-CoA supply to MiDAC deacetylase output
• Substrate/locus selectivity of MiDAC across tissues unmapped
• Structural basis of the nPDC interaction unknown